{"id":386,"date":"2026-06-08T02:29:14","date_gmt":"2026-06-08T06:29:14","guid":{"rendered":""},"modified":"2026-06-08T02:29:14","modified_gmt":"2026-06-08T06:29:14","slug":"longevity-medicine?","status":"publish","type":"post","link":"https:\/\/c2creset.ondigit.us\/?p=386","title":{"rendered":"Longevity Medicine?"},"content":{"rendered":"

Longevity Medicine<\/span><\/span><\/span><\/strong><\/span><\/span><\/span><\/p>\n

\"\"<\/p>\n

Therapies halting\/reversing the root causes of
\nage-related degeneration<\/strong><\/span><\/span><\/span><\/p>\n

Regenerative medicine helps create an environment in which missing or damaged tissue, that normally does not re-grow, can regenerate fully through cell manipulation and the use of scaffold materials that emit biochemical signals to spur someone’s stem cells into action.<\/span><\/span> <\/span><\/p>\n

Regenerative trial therapies have healed broken bones, bad burns, blindness, deafness, heart damage, nerve damage, and damage caused by ‘aging’. Aging also damages the stem cells required for regenerative therapies! <\/span><\/span><\/p>\n

In 2008, researchers have found what may be a shortcut to the growth of replacement organs from a patient”s own stem cells. It’s called re-cellularization<\/span><\/a>. <\/span><\/span><\/p>\n

The process takes a donor organ and chemically strips the cells from it, leaving only the scaffolding of the extracellular<\/span><\/a><\/span><\/span> matrix behind. Stem cells from the organ recipient are then used to re-populate the scaffold, creating a functioning organ ready for transplant with little risk of rejection.<\/span><\/span><\/p>\n

\"\"<\/span><\/span><\/p>\n

Researchers at Russia’s Altai State University developed a medicine that stimulates the body’s stem cell production, reinvigorates tissues and maintains them at levels which correspond with those of a biologically young organism.<\/span><\/span><\/p>\n

Synthetic biologists focus their attention on re-engineering the human genome, for ways to cure diseases. This also involves the epi-genome<\/span><\/a> and epi-genetics<\/span><\/a>.<\/span><\/span><\/p>\n

Other research showed that ‘splicing factor’ genes switch off as humans age<\/span><\/a>. Scientists found a way to restart the splicing by treating old cells with molecules that restore the levels of the splicing factors. Cells are now able to grow, and their telomeres are now longer, like in young cells.<\/span><\/span><\/p>\n